PathPresenter

Private

New JerseyHealthcare & Life Scienceshttps://www.pathpresenter.com

Last Round

Series A

Sep 12, 2024

Total Funding Raised

$7.5M

Momentum Score

25 /100

Company Overview

PathPresenter is a healthcare technology company that offers a secure, HIPAA-compliant platform for pathologists to share medical images and collaborate with colleagues worldwide.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Vertical SaaS, Medical AI, Telemedicine, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Freemium, Usage-Based SaaS, Marketplace Commission

AI Layer

Application

Keywords

digital pathology platformpathology workflow platformimage management systemIMStelepathologywhole slide imagingclinical pathology softwareLIS integrationvendor-agnostic platformpathology AI marketplaceremote second opinionsWSI viewerpathology educationresearch pathology software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PathPresenter Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PathPresenter Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 12, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Patrick Myles

Chief Executive Officer And Board Chair

Executive Team

Krushnavadan Acharya Acharya

CISO, Acting CTO,

Executive Team

KV Acharya

CSO CISO Acting CTO

Executive Team

PathPresenter Investors

Notable investors and investment history

Investor	Rounds
Modi Ventures	Series A
AVANT BIO	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 4, 2026
Grew 21% QoQ, from 38 to 46 employees.
Oct 3, 2025
Remote second opinion web portal now generally available on AWS.

View all signals

PathPresenter Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PathPresenter Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PathPresenter's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Jersey

Employee Range46

Year Founded2017

Last FundingSep 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.